Peter Breslin
Impact in
- Hematology top 5%
- Acute Myeloid Leukemia Research
- Hematopoietic Stem Cell Transplantation
- Hepatology top 10%
- Hepatocellular Carcinoma Treatment and Prognosis
Papers in
- Hematology 22
- Acute Myeloid Leukemia Research 15
- Hematopoietic Stem Cell Transplantation 8
-
- Hepatocellular Carcinoma Treatment and Prognosis 6
- Liver physiology and pathology 3
- Co-authors
- Jiwang Zhang (24 shared papers)Shanhui Liu (3 shared papers)Wei Qiu (9 shared papers)Lei Zhang (7 shared papers)Ameet R. Kini (8 shared papers)Andrew G. Volk (7 shared papers)Xianzhong Ding (6 shared papers)Chao Shi Niu (2 shared papers)
- Journals
- Blood (5 papers)Cell Death and Disease (2 papers)Stem Cell Reports (2 papers)Leukemia (2 papers)The Journal of Experimental Medicine (2 papers)
- Partner nations
- United StatesChinaGermany
In The Last Decade
Peter Breslin
37 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 74
- Hematology 298
- Hepatology 98
- Cancer Research 113
- Molecular Biology 401
- Geriatrics and Gerontology 22
Countries citing papers authored by Peter Breslin
This map shows the geographic impact of Peter Breslin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Breslin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Breslin more than expected).
Fields of papers citing papers by Peter Breslin
This network shows the impact of papers produced by Peter Breslin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Breslin. The network helps show where Peter Breslin may publish in the future.
Co-authors
The 25 scholars most cited alongside Peter Breslin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 39 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 103 | |
| 2 | 2022 | 103 | |
| 3 | 2022 | 100 | |
| 4 | 2014 | 85 | |
| 5 | 2009 | 69 | |
| 6 | 2009 | 60 | |
| 7 | 2020 | 52 | |
| 8 | 2015 | 49 | |
| 9 | 2016 | 43 | |
| 10 | 2019 | 43 | |
| 11 | 2016 | 42 | |
| 12 | 2011 | 37 | |
| 13 | 2018 | 35 | |
| 14 | 2020 | 33 | |
| 15 | 2016 | 32 | |
| 16 | 2010 | 30 | |
| 17 | 2015 | 26 | |
| 18 | 2013 | 22 | |
| 19 | 2018 | 22 | |
| 20 | 2022 | 22 |
About Peter Breslin
Peter Breslin is a scholar working on Hematology, Hepatology, Molecular Biology, Cancer Research and Immunology, having authored 39 papers that have together received 1.2k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (15 papers), Hematopoietic Stem Cell Transplantation (8 papers), Hepatocellular Carcinoma Treatment and Prognosis (6 papers), Cell death mechanisms and regulation (6 papers), NF-κB Signaling Pathways (4 papers), Liver physiology and pathology (3 papers), RNA Research and Splicing (2 papers) and Wnt/β-catenin signaling in development and cancer (2 papers). The work is most often cited by research in Hematology (298 citations), Hepatology (98 citations), Cancer Research (113 citations), Molecular Biology (401 citations) and Geriatrics and Gerontology (22 citations). Peter Breslin has collaborated with scholars based in United States, China and Germany. Frequent co-authors include Jiwang Zhang, Shanhui Liu, Wei Qiu, Lei Zhang, Ameet R. Kini, Andrew G. Volk, Xianzhong Ding, Chao Shi Niu, Minghui Tang and Manuel O. Dı́az. Their work appears in journals such as Blood, Cell Death and Disease, Stem Cell Reports, Leukemia and The Journal of Experimental Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.